Novo Nordisk A/S (NYSE:NVO)

53.26
Delayed Data
As of Mar 26
 +3.44 / +6.90%
Today’s Change
41.72
Today|||52-Week Range
54.38
+25.85%
Year-to-Date

Today’s Trading

Previous close49.82
Today’s open49.53
Day’s range48.81 - 54.38
Volume6,266,055
Average volume (3 months)1,453,048
Market cap$102.2B
Dividend yield1.37%
Data as of 4:06pm ET, 03/26/2015

Growth & Valuation

Earnings growth (last year)+6.78%
Earnings growth (this year)--
Earnings growth (next 5 years)+14.32%
Revenue growth (last year)+5.60%
P/E ratio5.3
Price/Sales7.05
Price/Book19.73

Competitors

 Today’s
change
Today’s
% change
BMYBristol-Myers Squibb+0.30+0.46%
CELGCelgene+0.67+0.57%
ABBVAbbVie-0.95-1.63%
GSKGlaxoSmithKline-0.69-1.46%
Data as of 4:14pm ET, 03/26/2015

Financials

Next reporting dateApril 30, 2015
EPS forecast (this quarter)$0.50
Annual revenue (last year)$15.7B
Annual profit (last year)$4.7B
Net profit margin29.82%

Profile

Sector
Health Technology
Industry
Pharmaceuticals: Major
Chief Executive Officer
Lars Rebien Sørensen
President &
Chief Operating Officer
Kåre Schultz
Corporate headquarters
Bagsvrd, --

Forecasts

To view my watchlist

Not a member yet?

Sign up now for a free account